Testing of controlled-release transdermal dosage forms. Product development and clinical trials.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Archives of Dermatology

• Publication date

  1987-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/ARCHDERM.1987.01660350161034PMID 2960274
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The identification of contact allergens by human assay. 3. The maximization test: a procedure for screening and rating contact sensitizers.

  1989cited by this paper
• Short-term quantitative in vitro cytotoxicity assay involving an S-9 activating system.

  1987cited by this paper
• Development and validation of an alternative dermal sensitization test: the mouse ear swelling test (MEST).

  1986cited by this paper
• Development of a murine local lymph node assay for the determination of sensitizing potential

  1986cited by this paper
• Evaluation of in vitro predictive tests for irritation and allergic sensitization.

  1986cited by this paper
• Initial validation of an In vitro test for predicting skin irritancy

  1986cited by this paper
• Pharmacokinetics and pharmacodynamics of transdermal dosage forms of 17 beta-estradiol: comparison with conventional oral estrogens used for hormone replacement.

  1985cited by this paper
• Treatment of hot flashes with transdermal estradiol administration.

  1985cited by this paper
• Toxicity determined in vitro by morphological alterations and neutral red absorption.

  1985cited by this paper
• Clonidine rate — controlled system: technology and kinetics

  1984cited by this paper
• Rapid colorimetric assay for cell viability: application to the quantitation of cytotoxic and growth inhibitory lymphokines.

  1984cited by this paper
• Pharmacokinetics of nitroglycerin and clonidine delivered by the transdermal route.

  1984cited by this paper
• Post-Marketing Surveillance of the Transiderm-Nitro Patch in General Practice

  1984cited by this paper
• Clinical experience with clonidine TTS

  1984cited by this paper
• Estrogen replacement therapy by transdermal estradiol administration.

  1983cited by this paper
• Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

  1983cited by this paper
• Transdermal clonidine for hypertensive patients.

  1983cited by this paper
• Dermal Drug Delivery Systems: A Review

  1983cited by this paper
• [Treatment of patients with angina pectoris in general practice with a new transdermal therapeutic system containing nitroglycerin (author's transl)].

  1982cited by this paper
• Transdermal scopolamine in the prevention of motion sickness at sea

  1981cited by this paper
• Programmed, systemic drug delivery by the transdermal route

  1979cited by this paper
• Percutaneous Drug Permeation

  1976cited by this paper
• Drug permeation through human skin: Theory and invitro experimental measurement

  1975cited by this paper
• Permeability of the skin.

  1971cited by this paper
• The identification of contact allergens by animal assay. The guinea pig maximization test.

  1970cited by this paper
• The Identification of Contact Allergens by Animal Assay. the Guinea Pig Maximization Test

  1969cited by this paper
• Regional variation in percutaneous penetration of 14C cortisol in man.

  1967cited by this paper
• Mechanism of percutaneous absorption. II. Transient diffusion and the relative importance of various routes of skin penetration.

  1967cited by this paper
• DELAYED CONTACT HYPERSENSITIVITY IN THE GUINEA PIG.

  1965cited by this paper
• Mechanism of percutaneous adsorption. I. Routes of penetration and the influence of solubility.

  1965cited by this paper

• Relating transdermal delivery plasma pharmacokinetics with in vitro permeation test (IVPT) findings using diffusion and compartment-in-series models.

  2021cites this paper
• In vivo human transfer of topical bioactive drugs among individuals: Estradiol and testosterone

  2012cites this paper
• Dermatotoxicology: historical perspective and advances.

  2010cites this paper
• Transdermal Estradiol and Testosterone Transfer in Man: Existence, Models, and Strategies for Prevention

  2010cites this paper
• In vitro human topical bioactive drug transdermal absorption: estradiol

  2009cites this paper
• Estradiol distribution and penetration in rat skin after topical application, studied by high resolution autoradiography

  2004cites this paper
• Percutaneous Absorption of Ketoprofen from Different Anatomical Sites in Man

  2004cites this paper
• Transdermal delivery of sex steroids for hormone replacement therapy and contraception. A review of principles and practice.

  2003cites this paper
• Optimisation of Treatment by Applying Programmable Rate-Controlled Drug Delivery Technology

  2002cites this paper
• Transdermal drug delivery system exposure outcomes.

  2000cites this paper
• cis-Urocanic Acid Induces Mast Cell Degranulation and Release of Preformed TNF--α: A Possible Mechanism Linking UVB and cis-Urocanic Acid to Immunosuppression of Contact Hypersensitivity

  1999cites this paper
• Toxicokinetic evaluation of a selegiline transdermal system in the dog.

  1997cites this paper
• Comparative serum estradiol profiles from a new once-a-week transdermal estradiol patch and a twice-a-week transdermal estradiol patch.

  1997cites this paper
• Prevention of contact hypersensitivity to topically applied drugs by ethacrynic acid: potential application to transdermal drug delivery

  1997cites this paper
• Sensitization of mice to topically applied drugs: albuterol chlorpheniramine, clonidine and nadolol

  1996cites this paper
• Medications Development for the Treatment of Pregnant Addicts and Their Infants

  1995cites this paper
• Skin Sensitivity and Transdermal Drug Delivery

  1994cites this paper
• Effect of d-limonene on the transdermal permeation of nifedipine and domperidone

  1994cites this paper
• Betablocking drugs in essential hypertension: transdermal bupranolol compared with oral metoprolol.

  1992cites this paper
• Transdermal Fentanyl

  1992cites this paper
• Skin biological issues in electrically enhanced transdermal delivery

  1992cites this paper
• Novel drug delivery systems. An overview of their impact on clinical pharmacokinetic studies.

  1991cites this paper
• In vitro release profile of estradiol transdermal therapeutic systems.

  1990cites this paper
• Kriterien zur Qualitätskontrolle von transdermalen Systemen

  1990cites this paper
• Adverse dermatologic reactions to transdermal drug delivery systems.

  1990cites this paper
• Pharmacology. I. Topical therapy in dermatology.

  1989cites this paper
• A review of contact dermatitis associated with transdermal therapeutic systems

  1989cites this paper
• Les médicaments transdermiques : étude de la toxicité cutanée d'un dispositif transdermique à base d'estradiol

  1989cites this paper
• Absorption characteristics of transdermally administered fentanyl.

  1989cites this paper
• Transdermal delivery of a melanotropic peptide hormone analogue.

  1988cites this paper